華揚聯眾(603825.SH):子公司與深圳北京中醫藥大學研究院簽訂合作框架協議
格隆匯11月27日丨華揚聯眾(603825.SH)公佈,為充分發揮公司控股子公司京深研產業資源優勢及研究院科研優勢,雙方擬以傳承中醫經典為基礎,圍繞中藥、中藥類食品保健品(如含藥食同源的中藥類特醫食品、特膳食品、普通食品、飲品和保健品等)、中藥類健康產品(如含中藥成分的美容、美體、保養、洗護類日化產品等消費品)、中醫健康大數據、健康知識傳播等方向展開全面合作,促進“產學研用”的有機融合,推進中醫藥現代化開發和科技成果有效轉化。京深研擬與深圳北京中醫藥大學研究院(研究院)進行合作,合作的具體情況如下:
京深研將通過委託研究院進行產品研發、樣品生產、產品測試、第三方成果購買等方式為研究院提供項目資金人民幣1600萬元。研究院將根據京深研具體委託要求,將項目資金用於為京深研提供服務,包括但不限於產品研發、測試、樣品生產、成果宣傳及相關課題研究等。
由於全民健康的生活理念日益普及,重要大健康市場前景廣闊,有待進一步挖掘市場需求。“顏值經濟”推動化粧品消費需求不斷增加,中藥化粧品迎來發展機遇,技術、消費習慣變化帶來營銷、渠道模式的更迭。公司控股子公司京深研與研究院此次合作,將有利於優化公司在中醫藥現代化開發產業及新健康領域的佈局,增強公司核心競爭力,符合公司的戰略發展規劃,符合公司和股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.